These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3836551)

  • 1. Congenital and acquired antithrombin III deficiency.
    Nakagawa M; Tsuji H; Maebo N; Toyoda T; Sawada S; Takamatsu H; Ijichi H
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1885-94. PubMed ID: 3836551
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinical value of antithrombin III].
    Vinazzer H; Bergmann H; Blauhut B
    Wien Med Wochenschr; 1984 Jun; 134(12):279-83. PubMed ID: 6380122
    [No Abstract]   [Full Text] [Related]  

  • 3. [Congenital antithrombin III deficiency. Use of concentrates in the prevention of thromboembolic episodes].
    Velasco F; Andrés P; Torres A
    Med Clin (Barc); 1985 Oct; 85(10):429. PubMed ID: 4079498
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin III. A review.
    Mortensen JZ; Jørgensen KA
    Dan Med Bull; 1983 Mar; 30(2):100-5. PubMed ID: 6342984
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired and congenital antithrombin III deficiency. Discussion of a clinical case].
    De Blasio F; De Filippis R; Bucci N; Formato A; Pezza A
    Arch Monaldi Mal Torace; 1987; 42(2):205-13. PubMed ID: 3333220
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombin-III (AT-III) deficiency spanning four generations.
    Mazza JJ; Mueller-Rizner NJ; Roberts RC
    Thromb Haemost; 1991 Dec; 66(6):737-8. PubMed ID: 1796421
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
    De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
    Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
    Schoch U; Zanetti E; von Felten A
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial antithrombin III deficiency.
    O'Donnell J; Day AJ; Snell AP
    N Z Med J; 1985 Jun; 98(781):481-3. PubMed ID: 3859772
    [No Abstract]   [Full Text] [Related]  

  • 14. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
    Kussmann J; Hirche H; Sengupta R
    Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency.
    Van Norman GA; Gernsheimer T; Chandler WL; Cochran RP; Spiess BD
    J Cardiothorac Vasc Anesth; 1997 Oct; 11(6):760-3. PubMed ID: 9327320
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial antithrombin III deficiency.
    Winter JH; Fenech A; Ridley W; Bennett B; Cumming AM; Mackie M; Douglas AS
    Q J Med; 1982; 51(204):373-95. PubMed ID: 7156320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K
    Thromb Res; 1991 Aug; 63(4):469-72. PubMed ID: 1755000
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Shibuya A; Ninomiya H; Nakazawa M; Nagasawa T; Yoda Y; Abe T
    Thromb Haemost; 1988 Dec; 60(3):495-7. PubMed ID: 3238652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three families with hereditary antithrombin III deficiency: the use of antithrombin III concentrate in one of the patients through the course of mastectomy (author's transl)].
    Hirasawa Y; Hayashi M; Nagaoka T; Kuto F; Tokuhiro H
    Nihon Ketsueki Gakkai Zasshi; 1981 May; 44(3):683-9. PubMed ID: 7331701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.